October 23, 2025

Aging and Hearing Loss: What’s Next

Cochlear implants are transforming how older adults hear, speak, and stay socially engaged.

KFF Health News

October 22, 2025

FDA Redefining Depression Treatment with New Approvals?

Researchers analyze FDA-approved and Phase 3 antidepressants from 2009 to 2025.

Conexiant

October 17, 2025

FDA Awards Nine CNPV Vouchers to Speed Reviews

Pilot aims to expedite access to high‑impact therapies by streamlining FDA review and strengthening sponsor–agency collaboration.

Conexiant

October 16, 2025

‘Dying Alone’: The Growing Challenge for Seniors

An increasing number of older adults are living and dying alone, highlighting the need for physicians to address end-of-life care for patients without family or caregivers.

KFF Health News

October 16, 2025

HHS Memo: Fringe Finds a Footing

From wheat fields to Washington: a decades-old fear about skies and 'sprays' rises again, colliding with science, social media, and the machinery of federal policymaking.

KFF Health News

October 14, 2025

When Yoga Raises, Not Reduces, Risk?

Iyengar yoga focuses on precision and alignment, but may not show as much benefit in improving balance as other physical activity.

Conexiant

October 14, 2025

Only 2% Screened: Closing the Male Gap

“Men would like to believe they’re indestructible, so a fracture doesn’t have the implication that it should."

KFF Health News

October 13, 2025

First Alzheimer's Test for Primary Care

Roche’s FDA-cleared Elecsys pTau181 blood test helps physicians rule out Alzheimer’s pathology early and streamline diagnosis.

Conexiant

October 10, 2025

FDA Broadens Label for Schizophrenia Drug

The FDA has approved a new long-acting injectable treatment option for adults with bipolar I disorder.

Conexiant